Search hospitals > Massachusetts > Boston
Massachusetts General Hospital
Claim this profileBoston, Massachusetts 02114
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Solid Tumors
4192 reported clinical trials
361 medical researchers
Summary
Massachusetts General Hospital is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Solid Tumors and other specialties. Massachusetts General Hospital is involved with conducting 4,192 clinical trials across 2,760 conditions. There are 361 research doctors associated with this hospital, such as David M. King, Sabine s Coppieters, MD, Ryan Sullivan, MD, and David Miller, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
KRAS positive
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park8 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Lung Cancer
104 reported clinical trials
167 drugs studied
Sabine s Coppieters, MDInvestigator site 2 - US00100873 years of reported clinical research
Studies Myasthenia Gravis
Studies Muscle Weakness
25 reported clinical trials
13 drugs studied
Ryan Sullivan, MDMassachusetts General Hospital3 years of reported clinical research
Expert in Melanoma
Expert in Solid Tumors
22 reported clinical trials
35 drugs studied
David Miller, MDParkland Memorial Hospital2 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Cervical Adenocarcinoma
21 reported clinical trials
40 drugs studied
Clinical Trials running at Massachusetts General Hospital
Multiple Myeloma
Breast Cancer
Cystic Fibrosis
Coronary Artery Disease
Melanoma
Plasma Cell Neoplasm
Colon Cancer
Giant Cell Tumor
Osteoporosis
Cancer
DVRd + Ciltacabtagene Autoleucel / ASCT
for Multiple Myeloma
This trial is testing a combination of four drugs followed by either a special cell therapy or a stem cell transplant in newly diagnosed multiple myeloma patients who can have a transplant. The drugs fight cancer and boost immunity, while the cell therapy reprograms immune cells to attack cancer, and the stem cell transplant rebuilds bone marrow.
Recruiting4 awards Phase 34 criteria
Long-term Follow-up
for Cilta-cel in Multiple Myeloma
The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.
Recruiting3 awards Phase 42 criteria
Dabrafenib + Trametinib
for Multiple Myeloma
This research study is studying a targeted therapy as a possible treatment for multiple myeloma. The names of the study drugs involved in this study are: * Trametinib * Dabrafenib
Recruiting3 awards Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Massachusetts General Hospital?
Where is Massachusetts General Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Massachusetts General Hospital accept?
What awards or recognition has Massachusetts General Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.